FREE EXCLUSIVE ACCESS

Get your personal China Global Profits Alert newsletter delivered to your inbox FREE each morning
Name
   
Email

AS SEEN ON

    
    
Category: Medical
Johnson & Johnson Continues To Be A Dynamo Dividend Stock
Johnson & Johnson Continues To Be A Dynamo Dividend Stock

Johnson & Johnsonboost its quarterly dividend by 10.2%

Freeport McMoRan Will Double Its Annual Dividend

About: Johnson & Johnson (NYSE: JNJ), JNJ, Johnson & Johnson, Procter & Gamble (NYSE: PG), quarterly dividend, dividend increase, Dividend Genius, dividend stock, stock dividend, dividend stocks, stock dividends
Bookmark and Share

Dow component Johnson & Johnson (NYSE: JNJ) reported first-quarter earlier this week and April is usually the month on the calendar when JNJ raises its dividend. The pharmaceuticals and consumer staples giant did not disappoint investors as the company said it will boost its quarterly dividend by five cents, or 10.2%, to 54 cents a share.

Freeport McMoRan Will Double Its Annual Dividend

Last week, we talked about the dividend legacy of Procter & Gamble (NYSE: PG), which has raised its payout for 54 consecutive years, but JNJ is no slouch either when it comes to a strong heritage of dividend increases. With its latest increase, JNJ has now raised its payout for 48 consecutive years.  While the company did lower its full-year guidance on Tuesday, this is still a stock long-term income-seeking investors can cozy up to. The new dividend takes the yield above 3% and the payout has more than doubled in the past six years.

The valuation is fair as JNJ shares trade at 13 times 2010 earnings and 11 times 2011 earnings. In addition, the company is taking steps to rein in costs. Those efforts could save the company as much as $900 million this year and up to $1.7 billion next year and that will only serve to strengthen an already strong balance sheet. We think a 49th consecutive dividend increase from JNJ is nearly a foregone conclusion.

 
Pfizer Could Raise Dividend By 20% Later This Month
Pfizer Could Raise Dividend By 20% Later This Month

Pfizer Could Raise Dividend By 20% Later This Month

 Pfizer Could Raise Dividend By 20% Later This Month

About: (Pfizer, PFE, Dividend Aristocrat's Index)
Bookmark and Share

Pfizer (NYSE: PFE), the world's largest drugmaker, may raise its quarterly dividend by as much as 20% later this month, according to a Credit Suisse analyst. Obviously, this is good news for wary Pfizer shareholders that endured a 50% dividend reduction earlier this year as the company attempted to conserve cash for its $68 billion acquisition of Wyeth.

            For years, the primary reason to own Pfizer's shares was the dividend and with a current payout of just 16 cents a share per quarter, it's tough to endorse Pfizer as a great dividend stock. Analyst Catherine Arnold believes the quarterly dividend could rise to 18.5 cents to 19.25 cents a share. That's a start and with expectations low for Pfizer's drug pipeline, any positive surprises on that front combined with a dividend hike could give a near-term jolt to the shares.

            Oddly enough, today's news about Pfizer's dividend comes just days after we told you about the company being removed from the Dividend Aristocrat's Index. Coincidence or not, we'd like to see Pfizer get back to its 2008 dividend. Pfizer currently yields 3.5%.

 
Standard & Poor's Dividend Aristocrats New Additions
Standard & Poor's Dividend Aristocrats New Additions

Big Changes Afoot For Dividend Aristocrats Index

 Big Changes Afoot For Dividend Aristocrats Index

About: (BF.B, Brown Forman, CTAS, Cintas, BBT, BB T, Legg Mason, LM, M&T Bank, MTB, State Street, SST, US Bankcorp USB, Avery Dennison, AVY, Gannett, GCI, Johnson Controls, JCI, General Electric, GE, Pfizer, PFE)
Bookmark and Share

There are dozens, if not hundreds of indexes tracking various sectors of the market, but for dividend hunters, the Standard & Poor's Dividend Aristocrats Index is one worth watching. The index equal-weighted and members are reweighted every quarter with membership reviews taking place every December. One key metric must be met to be considered a Dividend Aristocrat and that is at least 25 consecutive years of dividend increases, so when we've mentioned the index in the past, some of the constituents were somewhat puzzling to us.

            Some of 2008 and 2009's most noteworthy dividend cutters have been found among the Aristocrats, but that's set to change on December 18. Spirits maker Brown Forman (NYSE: BF.B) is slated to be a new addition. Brown Forman makes Southern Comfort and Jack Daniels among other familiar brands and the shares currently yield 2.2%. Another new addition will be uniform maker Cintas (Nasdaq: CTAS), which yields 1.6%.

            The departure list is lengthier and more infamous to be sure. Littered with dividend offenders from the financial sector, BB&T (NYSE: BBT), Legg Mason (NYSE: LM), M&T Bank (NYSE: MTB), State Street (NYSE: STT) and U.S. Bancorp (NYSE: USB) are among the departures from the Dividend Aristocrats Index.

            Joining the financials in saying “adios” to the index are Avery Dennison (NYSE: AVY), Gannett (NYSE: GCI), Johnson Controls (NYSE: JCI), General Electric (NYSE: GE) and Pfizer (NYSE: PFE).

 For more information about Dividend Genius, visit www.dividendgenius.com. To see the latest special offer from Dividend Genius, visit: http://www.dividendstockblog.com/dividend-genius-video.html